IMMUNE CHECKPOINT INHIBITOR NIVOLUMAB IN PEOPLE WITH RECURRENT SELECT RARE CNS CANCERS: RESULTS OF INTERIM ANALYSIS IN A NON-HEAVILY PRETREATED COHORT
Lorenzo Argao,Ying Yuan,Kathleen Wall,Tricia Kunst,Claudia Chambers,Elizabeth Vera, Caitlin Huguely,Masashi Watanabe,Ewa Grajkowska,Zied Abdullaev,Alvina Acquaye-Mallory,Kenneth Aldape, Brita Anderson,Lisa Boris,Daniela A. Bota,Nicole Briceno,Eric Burton,Anna Choi,P. J. Cimino,Pierre Giglio,Carlos Kamiya-Matsuoka,Priya U. Kumthekar,Jason Levine,Scott M. Lindhorst,Byram Ozer,Marissa Panzer,Tina Pillai,Lily Polskin,Drew Pratt,Martha Quezado, Renee Tweneboah-Koduah,Jing Wu,Terri S. Armstrong,Mark R. Gilbert,Marta Penas-Prado NEURO-ONCOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper